Table 2.
Comparison of clinical characteristics between the training cohort and the test cohort.
Training cohort | Text cohort | ||
---|---|---|---|
Cases | 248 | 244 | |
Age | ≤65 | 168 | 155 |
>65 | 80 | 90 | |
Gender | Female | 63 | 67 |
Male | 185 | 177 | |
Grade | G1 | 32 | 28 |
G2 | 141 | 153 | |
G3 | 62 | 55 | |
G4 | 2 | 0 | |
Stage | Stage I | 15 | 10 |
Stage II | 33 | 36 | |
Stage III | 42 | 36 | |
Stage IV | 124 | 128 | |
T (tumor) | T1 | 25 | 19 |
T2 | 61 | 69 | |
T3 | 49 | 47 | |
T4 | 86 | 80 | |
N (lymph node) | N0 | 79 | 88 |
N1 | 38 | 27 | |
N2 | 78 | 82 | |
N3 | 5 | 2 | |
HPV status by p16 testing | Negative | 42 | 30 |
Positive | 12 | 18 |